Ionis reports third quarter 2025 financial results and highlights progress on key programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Ionis reports third quarter 2025 financial results and highlights progress on key programs

Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 42c, Beats on Revenue; Offers FY25 EPS Guidance

October 29, 2025 7:08 AM EDT

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($0.80), $0.42 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $157 million versus the consensus estimate of $130.76 million.

GUIDANCE:

Ionis Pharmaceuticals sees FY2025 EPS of $875.00-$900.00, versus the consensus of... More